SH009 Injection

SH009 · Nanjing Sanhome Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SH009 Injection, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]